|
|||||
|
|
IL-1 trap. Regeneron/Novartis |
|
| Authors: | Gabay Cem |
| Affiliation: | Division of Rheumatology, University Hospital of Geneva, 26 Avenue Beau-Séjour, 1211 Geneva 14, Switzerland. cem.gabay@hcuge.ch |
| Abstract: | Regeneron and Novartis are co-developing the interleukin (IL)-1 antagonist IL-1 trap for the potential treatment of rheumatoid arthritis. In July 2002, a phase II trial was initiated and results are expected mid-2003. |
| Keywords: | |
| 本文献已被 PubMed 等数据库收录！ | |